pegloticase injection

Purikaxi has the function and efficacy of promoting the decomposition of uric acid and is used for adult gout patients who are ineffective or intolerant to conventional treatment.

Purikaxi is a recombinant urate oxidase that catalyzes the oxidation of uric acid into allantoin, which is then excreted by the kidneys, thereby reducing serum uric acid levels and achieving therapeutic effects.

In order to ensure the safety of patients and the best effect of the drug, before using Purikaxi, doctors usually require the patient’s serum uric acid level to be checked to determine the most appropriate dose. In addition, the drug is used by intravenous infusion and cannot be used by intravenous push. Because intravenous infusion can ensure that the drug enters the body slowly and evenly, thereby reducing the risk of adverse reactions.

It should be reminded that although Purikaxi has brought hope to many gout patients, it is not perfect. Some patients may experience facial flushing, urticaria, hypotension, nausea, vomiting, allergies and other reactions during or after drug treatment.